BRCA1 and ovarian neoplasm: Our exploratory transcriptomic analyses using TIMER predicted that dendritic cells and neutrophils as being differentially present in BRCA1-deficient vs. BRCA normal ovarian tumors, also supporting the concept that cellular immune responses are augmented in this setting.